We look forward to attending Cambridge Healthtech Institute's Inaugural event - Therapeutic Cancer Vaccines - showcasing Immunological Advances for Cancer Treatment.

ExpreS²ion CSO Farshad Guirakhoo will be speaking on Preclinical Proof Of Concept Studies of a Novel Human HER-2 Virus Like Particle as a Vaccine Candidate for Human Breast Cancers on April 23 at 4:30pm in the session on Peptide-Based Vaccines.

Learn more on Immune-Oncology Europe.